Publisher
Springer Science and Business Media LLC
Reference62 articles.
1. Tagalakis V, Patenaude V, Kahn SR, Suissa S. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE study cohort. Am J Med. 2013;126(9):832e13–e21. https://doi.org/10.1016/j.amjmed.2013.02.024.
2. Piazza G, Hohlfelder B, Goldhaber SZ. Handbook for venous thromboembolism. Cham: Springer International Publishing; 2015.
3. Australian Government. Venous thromboembolism clinical fact sheet. Australian Commission on Safety and Quality in Health Care. 2018. https://www.safetyandquality.gov.au/wp-content/uploads/2018/03/Venous-thromboembolism-short-clinician-fact-sheet.pdf. Accessed August 2019.
4. Tran HA, Gibbs H, Merriman E, Curnow JL, Young L, Bennett A, et al. New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism. Med J Aust. 2019;210(5):227–35. https://doi.org/10.5694/mja2.50004.
5. Bala A, Huddleston J, Goodman S, Maloney W, Amanatullah D. Venous thromboembolism prophylaxis after TKA: aspirin, warfarin, enoxaparin, or factor Xa inhibitors? Clin Orthop Related Res. 2017;475(9):2205–13. https://doi.org/10.1007/s11999-017-5394-6.